JC38 (Medicine) - Thyrotoxicosis and Hypothyroidism Flashcards

1
Q

Describe the physiological process of thyroid hormone synthesis

A

(1) Thyroglobulin biosynthesis
Thyroglobulin is synthesized in ribosomes of follicle cells
• Stimulated by thyroid-stimulating hormone (TSH) and cAMP
• Thyroglobulin in follicular cells is incorporated into exocytotic vesicles and extruded into colloid in lumen of follicle

(2) Thyroid hormone biosynthesis
Iodide trapping: Dietary iodide is taken up actively by Na-I symporter
• Oxidation: Iodide is oxidize to iodine by thyroidal peroxidase
• Iodination / Organification: Tyrosine residue in thyroglobulin is iodinated and form monoiodotyrosine (MIT) and diiodotyrosine (DIT)
Coupling: MIT and DIT are coupled together to form T3 and T4

(3) Secretion of thyroid hormones
• Stimulation of thyroid gland leads to endocytosis of colloid
• Endocytic vesicles fuse with lysosomes inside the follicular cells
• T3 and T4 are cleaved from the thyroglobulin and released into circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Forms of thyroid hormone transport in blood

A

o Thyroxine-binding globulin (TBG) (70%)
o Pre-albumin (15%)
o Albumin (15%)
o Free in circulation (< 1%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe activation and deactivation of thyroid hormone

A

Deiodination reactions in the peripheral tissues activate and inactivate TH
• Deiodinase Type 1 / 2 /3 to catalyse the reaction
• Deiodination of T4 into T3 (active) or reverse T3 (inactive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Effect of thyroid hormone on target cells

A

Thyroid hormones receptors (TRs)
• Located in the nuclei of target cells
• Bound to thyroid hormone response elements in DNA

Mechanism of action
• Cells receive free thyroid hormones (TH) from blood
T4 is deiodinated to T3 once inside cell
• T3 then enters nucleus and binds to thyroid hormone receptors (TRs)
• T3 triggers the dissociation of co-repressor from TRs and binding of co-activator
• TRs and T3 forms a complex with nuclear receptor- retinoid X receptor (RxR) to initiate gene transcription
• Results in mRNA and protein production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Compare T3 and T4

  • Mode of transport in blood
  • Pool size
  • Source
  • Location
  • Activity
  • Onset of action
  • Half-life
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Compare T3 and T4

  • Mode of transport in blood
  • Pool size
  • Source
  • Location
  • Activity
  • Onset of action
  • Half-life
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Effect of thyroid hormone on target end-organs

A
  1. Increase Basal metabolic rate: Increase O2 consumption and ATP production
  2. Growth: permissive effect on growth hormone, protein synthesis, bone remodeling, coordinate PTH and Calcitonin
  3. Biphasic control of carbohydrate and lipid synthesis/ breakdown: Increase glucose and lipid metabolism, remove LDL and cholesterol
  4. CVS: increase contractility, permissive effect on catecholamines, vasodilation
  5. CNS: development and behavior
  6. Temperature: heat production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Differentiate hyperthyroidism and thyrotoxicosis

A

Thyrotoxicosis is defined as the state of thyroid hormone excess

Hyperthyroidism is the result of excess thyroid function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Causes of primary hyperthyroidism

A

 Grave’s diseases
 Toxic multinodular goitre
 Toxic adenoma
 Metastatic thyroid cancer
 Mutation of TSH receptor
 Mutation of Gsa (McCune-Albright syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Causes of secondary hyperthyroidism

A

 TSH-secreting pituitary adenoma

 Chorionic gonadotropin-secreting tumour

 Gestational thyrotoxicosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Causes of thyrotoxicosis without hyperthyroidism

A

(Very similar to transient hypothyroidism)

Subacute (De Quervain’s) thyroiditis

Silent thyroiditis

Destructive thyroiditis
• Amiodarone/ Irradiation
• Release of TH into blood

Levothyroxine (T4) overdose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Causes of primary hypothyroidism

A

 Iodine deficiency

 Autoimmune hypothyroidism
• Hashimoto’s thyroiditis
• Atrophic thyroiditis

 Congenital hypothyroidism
• Congenital absence or ectopic thyroid gland
• Thyroid gland dysgenesis (80 – 85%)
• Dyshormonogenesis (10 – 15%)
• TSH-R antibody-mediated (5%)

 Infiltrative hypothyroidism
• Sarcoidosis
• Amyloidosis
• Scleroderma
• Riedel’s thyroiditis

 Drug-induced hypothyroidism
• Amiodarone
• Lithium

 Iatrogenic hypothyroidism
• 131I treatment
• Subtotal or total thyroidectomy
• External irradiation of neck

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes of secondary hypothyroidism

A

 Hypothalamic disease
• Hypothalamic tumours
• Trauma/ Infiltrative disorders

 Hypopituitarism
• Pituitary tumour
• Pituitary surgery or irradiation
• Sheehan’s syndrome
• Trauma/ Infiltrative disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Causes of transient hypothyroidism

A

 Subacute (De Quervain’s) thyroiditis
 Silent thyroiditis (including post-partum thyroiditis)
 Withdrawal of supraphysiologic T4 treatment
 Post-131I treatment
 Post-subtotal or total thyroidectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tests for thyroid function

Which marker screens for thyroid dysfunction?

A
  1. Serum free thyroid hormone fT3, fT4: unbound thyroid hormone
  2. Serum TSH
  3. Serum total T4: T4 bound to plasma-binding proteins

Serum TSH screens for thyroid dysfunction

MOST sensitive indicator of thyroid function due to short t1/2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Symptoms of hyperthyroidism

A

 Hyperactivity/ Irritability/ Dysphoria
 Heat intolerance and increased sweating
 Palpitations
 Fatigue and weakness
 Weight loss with increased appetite

 Hair loss
 Diarrhea
 Polyuria
 Oligomenorrhea and amenorrhea
 Loss of libido

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Signs of hyperthyroidism

A

 Tachycardia and AF
 Tremor
 Goitre
 Warm and moist skin
 Muscle weakness and proximal myopathy

 Lid lag and lid retraction
• Permissive effect on catecholamine leading to sympathetic overactivity
• Sustained contraction of superior tarsal muscles

 Thyroid eye signs

 Pretibial Myxoedema
 Gynecomastia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

List all thyroid eye signs

A

Periorbital edema

Lid lag and lid retraction

Exophthalmos (proptosis)

Ophthalmoplegia (extra-ocular muscle involvement)

Corneal involvement (exposure keratitis)

Vision loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Symptoms of hypothyroidism

A

General:
 Fatigue and weakness
 Cold intolerance
 Weight gain with decreased appetite
 Hair loss, Dry skin

Neuro:
 Difficulty concentrating and poor memory
 Impaired hearing
 Paraesthesia

GI:
 Constipation
Respi:
 Dyspnea
 Hoarseness
Gyn:
 Menorrhagia (later oligomenorrhea or amenorrhea)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Signs of hypothyroidism

A

Skin:
 Dry and cold skin
 Alopecia
 Puffiness of face, hands and feet/ Myxedema

Cardiovascular:
 Bradycardia
 Peripheral non-pitting edema

Neuro:
 Hyporeflexia
 Delayed tendon reflex relaxation
 Carpal tunnel syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Grading of Grave’s ophthalmopathy

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Pathophysiology of periorbital edema and proptosis

A

 T-cells and autoantibodies are reactive to extraocular muscles and retro-orbital tissues
 Inflammation leads to deposition of collagen and glycosaminoglycan in muscles
 Swelling of extraocular muscle and periorbital edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Pathophysiology of Proptosis due to thyrotoxicosis

A

 ONLY occurs in Grave’s disease
 Protrusion of eyeball from orbit
 Sclera is not covered by the lower eyelid
 Eyes are anterior to the superior orbital margin when viewed from the back

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How to examine for proptosis

A

 ONLY occurs in Grave’s disease
 Protrusion of eyeball from orbit
 Sclera is not covered by the lower eyelid
 Eyes are anterior to the superior orbital margin when viewed from the back

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Complications of proptosis due to thyrotoxicosis
Opthalmoplegia/ Diplopia Corneal ulceration Chemosis Conjunctivitis Optic atrophy
26
Thyrotoxicosis hand signs
Fine tremor\* - Due to sympathetic overactivity Sweating, warm and moist skin\* - Due to sympathetic overactivity Onycholysis - Separation of nail from bed Palmar erythema - Signs of Grave’s disease Finger clubbing Thyroid acropachy - Soft-tissue swelling of hands and finger clubbing Abnormal pulse  Sinus tachycardia (Sympathetic overactivity)  Atrial fibrillation (Shortened refractory period of atrial cells related to sympathetic drive)  Bounding pulse and wide pulse pressure (High cardiac output associated with AS murmur)
27
Signs of thyrotoxicosis on arms and legs
Arms * *- Proximal myopathy** * *- Hyperreflexia** Legs **- Proximal myopathy**: Ask patient to stand up from squatting position **- Pretibial myxedema**  Occurs in Grave’s disease and rarely Hashimoto’s thyroiditis  Localized non-pitting edema of skin  Bilateral firm, elevated dermal nodules and plaques  Can be pink, brown or skin-colored  Hyaluronic acid accumulates in dermis and subcutis
28
Hypothyroidism hand signs
Peripheral cyanosis - Reduced cardiac output Palmar crease pallor Anemia due to • Anemia of chronic disease • Iron deficiency (menorrhagia) • Folate deficiency (bacterial overgrowth) Dry and cool skin Yellow discoloration  Due to hypercarotenemia  Slowing down of hepatic metabolism of carotene Abnormal pulse Carpal tunnel syndrome  Sensory loss as carpal tunnel is thickened in myxoedema
29
Hypothyroidism signs on arms and legs
Arms - Proximal myopathy - “Hung-up” biceps reflex Legs - Non-pitting edema/ Myxoedema - “Hung-up” Achilles reflex  Rapid dorsiflexion followed by slow plantar flexion after the tendon is tapped
30
Signs of hypothyroidism in children/ newborn
Newborn: Cretinism/ Short stature/ Mental retardation/ Puffy face/ Deaf mutism/ Protuberant abdomen/ Umbilical hernia Children: Retardation of growth, mental retardation
31
Advantage and limitations of serum TSH test
Advantage: * MOST sensitive indicator of thyroid function due to short t1/2 * Normal TSH excludes a primary hyperthyroidism * Does NOT exclude secondary abnormalities (hypothalamic or pituitary) Limitations: * Cannot indicate pituitary disease * High TSH can mean hypothyroidism or secondary hyperthyroidism * Low TSH can mean hyperthyroidism or secondary hypothyroidism * Low TSH in 1st trimester pregnancy, high dose corticosteroid or dopamine use
32
Indication for fT3 and fT4 test Why is total T4 less useful?
Hypothyroidism: only need fT4 (fT3 normal in 25% patients due to adaptive deiodinase response) Hyperthyroidism: need both fT3 and fT4 (2-5% have only fT3 elevation in T3 toxicosis) Total T4 is related to thyroxine-binding globulin with confounding factors: * High in pregnancy, oral contraceptive, hormonal therapy * Low in androgen use, hypoalbuminaemia
33
List 3 thyroid autoantibodies and indications
Thyroid antibodies • Thyrotropin receptor antibodies (TRA) (Anti-TSH antibodies) • Anti-thyroid peroxidase (TPO) antibodies • Anti-thyroglobulin (TG) antibodies Anti-TSH: Grave's disease Anti- TPO: Hashimoto thyroiditis Anti-TG: Multinodular goiter
34
Pathophysiology of Grave's disease
Autoimmune disease: Lymphocytes produce autoantibodies against self-antigen TSH receptor Thyrotropin-receptor antibody (TRAb) stimulates TSH receptor on thyroid gland: Stimulate thyroid cell hyperplasia and TH release
35
Clinical diagnosis of Grave's disease
1. Diffusely enlarged thyroid gland 2. High fT3 and fT4, Suppressed TSH 3. Diffuse radioactive iodine uptake in scintigraphy scan 4. Positive TSH receptor autoantibody in serum
36
Function of radioisotope thyroid scan
*Functional assessment of thyroid* Increased uptake: * Grave's disease: diffuse uptake * TSH-secreting pituitary adenoma: diffuse uptake * Toxic adenoma: focal area of uptake only * Multinodular goiter: heterogenous uptake Decreased uptake: * Thyroiditis * T4 overdose * Iatrogenic: e.g. hemithyroidectomy *Guide FNAC decision* o Hot nodules do NOT require FNAC o Cold nodules require FNAC
37
S/S of Grave's disease
Goiter S/S hyperthyroidism Exophthalmos/ Proptosis Pretibial Myxoedema S/S of related autoimmune diseases: MG, DM
38
Complications of hyperthyroidism
Thyroid storm Thyrotoxic period paralysis (HypoK) Atrial fibrillation and heart failure
39
Clinical use of Thyrotropin-receptor antibody (TRAb)
1. Prognostic indicator of Antithyroid drug against Grave's disease: negative TRAb after Tx means better prognosis 2. Forecast neonatal Grave's disease (TRAb passes through placenta) 3. Diagnosis of Grave's disease and monitor response to antithyroid drugs
40
Outline all treatment options for Grave's disease
1. Antithyroid drugs: * Thiouracil derivatives: Methimazole, carbimazole, propylthiouracil * Lithium 2. Surgery: thyroidectomy 3. RAI therapy 4. Ancillary drugs: Sedatives, B-blocker, Iodine
41
Compare surgery, Anti-thyroid and RAI therapy * Relapse risk * Hypothyroidism risk * Long-term complication risk * Onset of therapeutic effect
42
Beta-blocker for hyperthyroidism * Indication * Example * MoA * S/E
* Indication: Thyrotoxic crisis, before surgery to prevent thyroid storm * Example: Propanolol * MoA  Block β1-adrenoreceptors in heart • Relive palpitations  Block β1-adrenoreceptors in brain • Relieve anxiety  Block β2-adrenoreceptors in skeletal muscle • Relieve tremor * S/E:  Bronchospasm  Hypoglycemia  Heart failure (↓ CO)  Coronary artery spasm
43
Lugol's solution * Indication * Contraindication * MoA * S/E
* Indication: rapid onset, short-term use before thyroidectomy/ thyroid storm * Contraindication: pregnancy and breast-feeding * MoA: High iodine concentration inhibits H2O2 and peroxidase \> inhibit iodination of thyroglobulin and production of T3, T4 Decrease size and vascularity of hyperplastic thyroid gland Decrease bleeding risk during surgery * S/E: Hypersensitivity (fever, rash, angioedema, conjunctivitis..etc)
44
Thionamides * Indication * Tx course * Examples * MoA * S/E
* Indication: Children/ Pregnancy/ Mild- moderate disease * Tx course: 12 - 18 months, onset of effects takes 4 weeks * Examples: Carbimazole/ Methimazole/ Propylthiouracil (PTU) * MoA: Carbimazole/ Methimazole: Inhibit the action of peroxidase • Inhibit iodination (organification) of tyrosine residues of thyroglobulin • Inhibits coupling of iodotyrosine and production of T3 and T4 • Suppress intra-thyroidal antigen-presenting cells PTU: Inhibits peripheral conversion of T4 into T3 * S/E: Skin rash, urticaria and pruritis Agranulocytosis (first 2 months, fever, sore throat) Rare: Hepatotoxicity, Acute arthralgia, Cholestatic jaundice, ANCA vasculitis
45
Describe absorption of thionamide derivatives Recommendation during pregnancy
Rapid absorption into thyroid in minutes All transferable into milk Metimazole/ Carbimazole more teratogenic than PTU \>\> Give PTU until second trimester then change to methimazole/ Carbimazole
46
Predictive patient features associated with higher recurrence of thyroid disease after anti-thyroid drugs
1. Larger goiter 2. Positive family history 3. High initial T3 or T3/T4 ratio 4. Shorter course of Tx 5. Failure to normalize TSH 6. High TSH receptor antibody levels
47
Surgical treatment options for diffuse toxic goiter Pre-op preparation
Bilateral subtotal thyroidectomy Unilateral total and contralateral subtotal lobectomy Near total thyroidectomy Pre-op preparation: * Antithyroid until euthyroid * Beta-blocker for 2 weeks * Lugol's solution 2-3 days before
48
Indications for surgical treatment of diffuse toxic goiter
1. Young age 2. Failed medical treatment 3. Refuse/ Refractory to anti-thyroid drugs 4. Thyroid eye signs 5. Pregnancy/ breast-feeding 6. Refuse/ Refractory to RAI therapy 7. Excessively large goiter +/- compressive symptoms
49
Complications of thyroid surgery
 Hypoparathyroidism  Thyroid storm  Tracheomalacia - trachea cartilage collapse  Vocal cord paralysis: RLN or SLN damage  Wound complications: seroma, hypertrophic scar  Hemorrhage • Compression and edematous effect compresses on trachea
50
RAI therapy * Indication * Contraindication * MoA * S/E
Indications: * Thyrotoxic heart disease; Refractory to antithyroid drugs; ablation of residual tumor after thyroidectomy; Relapse post-op; C/O surgery Contraindication: * Pregnancy/ breast-feeding (transplacental, fetal risks) MoA: * Taken up by Na-I symporter and incorporated into thyroglobulin * Emit B-radiation to cause necrosis of follicular cells, fibrosis and destroy colloid * Destroy intra-thyroid T-suppression cells, Inhibit release of TSH-receptor antibodies S/E: * Hypothyroidism * Risk of thyroid eye disease after Tx * Thyroid storm due to radiation thyroiditis
51
Advantage of RAI therapy
Low relapse rate Simple procedure Economical No immediate complications
52
Pathogenesis of Grave's opthalmopathy
1. TSH-receptor antibody stimulate orbital fibroblasts to differentiate into adipocytes/ adipogenesis 2. Increase TSH receptor expression on orbital fibroblast after differentiation into adipocytes 3. Orbital adipocytes hypertrophy and exerts pressure on eyeball
53
Histological features of Grave's ophthalmopathy * At extra-ocular muscles, retrobulbar fat and optic nerve
Extra-ocular muscles: edema, mononuclear cell infiltration, Mucopolysaccharide deposits, Fibrosis Retrobulbar fat: Lymphocyte infiltration, fat replaced by fibrous tissue, collagen tissue replaced by hyaluronic acid Optic nerve: atrophy, replaced by fibrous and fatty connective tissue
54
Ophthalmopathy must be related to hyperthyroidism True or False?
False Can be hyper-, hypo- or euthyroid 80% opthalmopathy first develop eye signs within 18 months of thyrotoxicosis
55
Treatment of Grave's opthalmopathy
1. Anti-thyroid treatment to achieve euthyroid 2. Immunosuppressants against infiltrative ophthalmopathy: * Steroid - IV or oral methylprednisolone * Cyclosporin A * Plasmapharesis for autoantibody * Immunoglobulin * TNF-a inhibitor * IGF-1 receptor inhibitor 3. Orbital irradiation 4. Orbital decompression/ extra-ocular muscle operation
56
Thyrotoxic period paralysis * Pathophysiology
Pathophysiology: hyperthyroidism results in □ ↑Na+/K+/ATPase activity + ↑insulin release (esp after carbohydrate load) → intracellular shift of K+ □ Consequences: paralysis and hypokalemia
57
Thyrotoxic Periodic Paralysis (TPP) Clinical presentation: signs, course, S/S, precipitating events
Always preceded by thyrotoxic S/S (thyrotoxic state essential for pathogenesis) Attacks of motor paralysis: proximal \> distal, LL \> UL, seldom respiratory/bulbar muscles → Signs: typically hypotonia with hypo/areflexia → Course: weekly/monthly attacks lasting mins-days Precipitants: - Events a/w ↑adrenaline release: rest after strenuous activity, stress, SABA use - Events a/w ↑insulin release: namely ↑carbohydrate load Cardiac arrhythmia due to severe hypoK
58
Management of Thyrotoxic Periodic Paralysis (TPP)
Mx: usually spontaneous recovery □ Cardiac monitoring □ K supplement: use IV K 10-20mmol/h over 2h to accelerate recovery → Watch out for rebound hyperkalemia (40-59%) when transcellular shift reverses → IV propranolol may be useful to reverse excessive ↑Na+/K+/ATPase activity in refractory cases □ Manage hyperthyroidism □ Other prophylactic Tx: low salt diet, moderate carbohydrate intake ± propranolol
59
4 clinical patterns of hypothyroidism
Cretinism Juvenile myxedema Adult myxedema Myxedema coma
60
Ddx painless thyroiditis
Autoimmune: Lymphocytic thyroiditis, Atrophic thyroiditis, Hashimoto's thyroiditis Silent thyroiditis e.g. Post-partum thyroiditis
61
Hashimoto's thyroiditis * Risk factors * Pathology * Histological features
RFs: older female, family history, HLA-DR3, High iodine intake, smoking Pathology: T-cell mediated autoimmune disease against thyroid tissue Anti-thyroid antibody after T-cell mediated thyroid injury: Anti-thyroglobulin, Anti-TPO Histology: profuse lymphocytic infiltration, lymphoid germinal centres and destruction of thyroid follicles ± fibrosis
62
Clinical presentation of Hashimoto's thyroiditis
Clinical presentation: □ Goitre: usually small or moderately sized, diffuse, painless → Characteristically firm, rubbery → Atrophic variant: predominantly TSHr-blocking Ab → no goiter □ Hypothyroidism (25%) Natural Hx: gradual loss in thyroid function over years
63
Hashimoto's thyroiditis ## Footnote Investigations Management
Ix: □ TFT: may have ↑TSH + ↓fT4 □ Thyroid Ab: anti-TPO Ab (90-100%), anti-Tg Ab (80-90%), anti-TSHr (10-20%) Mx: T4 replacement: treats hypothyroidism + shrinks goiter
64
List 4 types of subacute thyroiditis
□ Subacute granulomatous (de Quervain’s, giant cell) thyroiditis □ Subacute lymphocytic thyroiditis □ Postpartum thyroiditis □ Palpation thyroiditis
65
Subacute thyroiditis ## Footnote Clinical course S/S Management
S/S: ## Footnote □ Pain at thyroid, exacerbate by swallowing or neck movement, only in Quervain's, not others □ Goitre: palpable ± tenderness □ Fluctuating thyroid status > transient hypothyroidism or thyrotoxicosis without hyperthryroidism □ Systemic symptoms: fever, ↑WBC, ↑ESR Clinical course: □ Thyrotoxic phase (4-6w) → Due to damage to follicles release of stored T4 until depletion → ↓iodine uptake (↓TSH, follicular damage) □ Hypothyroid phase (4-6mo) due to damage to follicular cells → ↓synthesis of thyroid hormones □ Resolution Mx: self-limiting → do NOT give antithyroid medications □ No Mx: spontaneous resolution! □ *NSAIDs/corticosteroids* for severe cases → manage systemic upset + pain □ *Temporary β-blocker* for hyperthyroid phase (usually mild) → for symptomatic control only □ *Temporary T4 replacement* for hypothyroid phase if pronounced or symptomatic
66
Causes of simple goiter
``` □ Causes: during ↑requirement (eg. pregnancy, pubertal) or from food (goitrogen, iodine excess/deficiency) ```
67
multinodular goiter Pathology TFT results S/S
Pathology: recurrent episodes of hyperplasia and involution (due to unknown stimulus) → hyperplastic nodules growing at varying rates → some may secrete thyroid hormone autonomously (toxic MNG, Plummer disease) TFT findings: → 25% with complete suppression of TSH → T4/3 can be within reference range (subclinical thyrotoxicosis) or elevated (toxic MNG) S/S: classically AF + multinodular goitre in elderly → Large goiter ± compressive S/S or retrosternal extension → Haemorrhage into nodule/cyst → sudden painful swelling → Thyrotoxic symptoms/complications, eg. AF
68
Management of multinodular goiter
Mx: → No treatment + annual TFT to screen for toxic MNG in small, non-toxic MNG - Consider T4 suppression therapy in selected patients → aim low-normal TSH → Early definitive treatment for large or toxic MNG (as relapse is invariable after cessation of ATD)49 - Total thyroidectomy for large goitres with compression or cosmetic concerns - RAI for small toxic goitres
69
Congenital hypothyroidism Screening method Causes
Neonatal cord blood TSH screening: fT4 \<12pmol/L, TSH \>7mlU/L Causes: 1. Athyroesis 2. Dyshormonogenesis 3. Ectopic thyroid gland 4. Hypothalamic - Pituitary hypothyroidism 5. Maternal factors: Anti-thyroid drugs, Iodine deficiency, TSH-autoantibodies, Premature birth 6. Associated conditions: Down's syndrome, Trisomy 18…etc
70
Cardiac precaution with thyroid disease
1. Hypothyroidism - lead to hyperlipidaemia due to decrease lipolysis, increase risk of Coronary atherosclerosis 2. Must treat coronary atherosclerosis prior to T4 supplementation: Initiation of thyroxine raises CO and worsens IHD 3. Give 4-6 weeks to equilibrate thyroxine
71
Myxedema coma * S/S * Complication * Tx
 General features • Severe hypothyroidism with hypothermia, respiratory failure with hypoxia and coma, convulsions, confusion  General management • Treatment of precipitating causes • Maintenance of body temperature • Correction of hypoglycemia with D10 • Correction of fluid and electrolytes with NS ± vasopressors  Medical treatment • Liothyronine (T3) • Levothyroxine (T4)